FOLFOXIRI


FOLFOXIRI is a chemotherapy regimen for treatment of advanced colorectal cancer. The role of FOLFOXIRI in colorectal cancer has been reviewed.
The chemotherapy regimen is made up of the following four drugs:
It is usually given with bevacizumab, unlike FOLFIRINOX for treatment of advanced pancreatic cancer. Also, the doses are slightly dissimilar to FOLFIRINOX.
Upfront FOLFOXIRI with bevacizumab can be followed by fluoropyrimidine with bevacizumab maintenance.